Now showing items 1-20 of 3420

    • Pure neural leprosy-mind the diagnosis.

      Brandsma, W; Post, E; Wagenaar, I; Alam, K; Shetty, V; Husain, S; Prakoeswa, CRS; Shah, M; Tamang, KB (2021-11-23)
    • Health technology assessment applied to emergency preparedness: a new perspective.

      Miglietta, Alessandro; de Waure, Chiara; Chronaki, Catherine; Wild, Claudia; Favaretti, Carlo; Timen, Aura; Edelstein, Michael; Petelos, Elena (2021-07-16)
    • Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic.

      Tanis, Charlotte C; Leach, Nina M; Geiger, Sandra J; Nauta, Floor H; Dablander, Fabian; van Harreveld, Frenk; de Wit, Sanne; Kanters, Gerard; Knoppers, Jop; Markus, Diederik A W; et al. (2021-07-15)
    • Effects of exposure to surrounding green, air pollution and traffic noise with non-accidental and cause-specific mortality in the Dutch national cohort.

      Klompmaker, Jochem O; Janssen, Nicole A H; Bloemsma, Lizan D; Marra, Marten; Lebret, Erik; Gehring, Ulrike; Hoek, Gerard (2021-07-14)
      We followed approximately 10.5 million adults (aged ≥ 30 years) living in the Netherlands from 1 January 2013 until 31 December 2018. We used Cox proportional hazard models to evaluate associations of residential surrounding green (including the average Normalized Difference Vegetation Index (NDVI) in buffers of 300 and 1000 m), annual average ambient air pollutant concentrations [including particulate matter (PM2.5), nitrogen dioxide (NO2)] and traffic noise with non-accidental and cause-specific mortality, adjusting for potential confounders.
    • Development of a mechanism for the rapid risk assessment of cross-border chemical health threats.

      Hague, Charlotte; Orford, Rob; Gaulton, Tom; Thomas, Eirian; Hall, Lisbeth; Duarte-Davidson, Raquel (2021-07-14)
    • Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries.

      Staadegaard, Lisa; Caini, Saverio; Wangchuk, Sonam; Thapa, Binay; de Almeida, Walquiria Aparecida Ferreira; de Carvalho, Felipe Cotrim; Fasce, Rodrigo A; Bustos, Patricia; Kyncl, Jan; Novakova, Ludmila; et al. (2021-07-13)
    • Circadian rhythm and time-of-day-effects of (anti)oxidant biomarkers for epidemiological studies.

      Ruskovska, Tatjana; Beekhof, Piet; Velickova, Nevenka; Kamcev, Nikola; Jansen, Eugène (2021-07-12)
      Various biomarkers of oxidative stress and redox status have been used in a number of clinical and epidemiological studies related to diseases and conditions that involve disturbances of the redox balance. However, a comprehensive study of diurnal variations of a set of biomarkers has not been conducted so far. Therefore, the aim of this study is to investigate circadian rhythm and time-of-day-effects of a set of frequently used biomarkers of oxidative stress, redox and antioxidant status in serum/plasma. These biomarkers include Reactive Oxygen Metabolites (ROM), Biological Antioxidant Potency (BAP), Total Thiols in Proteins (TTP), high-sensitive C-Reactive Protein (CRP) and Uric Acid (UA). During a 24-hr study, blood sampling was conducted 6 times at 4-hr intervals. The presence of circadian rhythm was analyzed with CircWave analysis, whereas the effect of time was analyzed with Repeated Measures ANOVA (RM-ANOVA). Thereby, the main focus was on the time points in working hours (8, 12 and 16 hr), which are used frequently in practice. Of all investigated biomarkers, only TTP in males demonstrated statistically significant circadian rhythm (p = 0.040). A statistically significant effect between all six time points with RM-ANOVA was observed for ROM, TTP and UA in both genders, and for BAP in females only. No statistically significant differences were observed between the time points 8 hr and 12 hr for any of the biomarkers that were assessed in our study. In conclusion, diurnal variations in some of the studied biomarkers that we demonstrate here should be taken into account when designing and conducting clinical and epidemiological studies. It is advised to standardize the time of sampling with a preference in the morning hours.
    • Examining the distribution and impact of single nucleotide polymorphisms in the capsular locus of serotype 19A.

      Arends, D W; Miellet, W R; Langereis, J D; Ederveen, T H A; van der Gaast-de Jongh, C E; van Scherpenzeel, M; Knol, M J; van Sorge, N M; Lefeber, D J; Trzciński, K; et al. (2021-07-12)
      Streptococcus pneumoniae serotype 19A prevalence has increased after implementation of PCV7 and PCV10 vaccines. In this study, we have provided, with high accuracy, the genetic diversity of the 19A serotype in a cohort of Dutch invasive pneumococcal disease patients and asymptomatic carriers obtained in the period 2004-2016. Whole genomes of the 338 pneumococcal isolates in this cohort were sequenced and their capsule (cps) loci compared to examine the diversity and determine the impact on the production of CPS sugar precursors and CPS shedding. We discovered 79 types with a unique CPS locus sequence. Most variation was observed in the rmlB and rmlD genes of the TDP-Rha synthesis pathway, and in the wzg gene, of unknown function. Interestingly, gene variation in the cps locus was conserved in multiple alleles. Using RmlB and RmlD protein models, we predict that enzymatic function is not affected by the single nucleotide polymorphisms as identified. To determine if RmlB and RmlD function was affected, we analyzed nucleotide sugar levels using UHPLC-MS. CPS precursors differed between 19A cps locus subtypes, including TDP-Rha, but no clear correlation was observed. Also, a significant difference in multiple nucleotide sugar levels was observed between phylogenetically branched groups. Because of indications of a role for Wzg in capsule shedding, we analyzed if this was affected. No clear indication of a direct role in shedding was found. We thus describe genotypic variety in rmlB, rmlD and wzg in serotype 19A the Netherlands, for which we have not discovered an associated phenotype.
    • Wild ungulate species differ in their contribution to the transmission of Ixodes ricinus-borne pathogens.

      Fabri, Nannet D; Sprong, Hein; Hofmeester, Tim R; Heesterbeek, Hans; Donnars, Björn F; Widemo, Fredrik; Ecke, Frauke; Cromsigt, Joris P G M (2021-07-10)
    • Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL.

      van der Moeren, N; Zwart, V F; Goderski, G; Rijkers, G T; van den Bijllaardt, W; Veenemans, J; Kluytmans, J A J W; Pas, S D; Meijer, A; Verweij, J J; et al. (2021-07-08)
      The DAA had an overall specificity of 100% (95%CI 97.9%-100%) and sensitivity of 73% (95%CI 61.3%-82.7%) for the clinical samples. Sensitivity was 86% (CI95% 74.6%-93.3%) for samples with Ct-value below 30. Both the DAA and RRA detected SARS-CoV-2 up to a dilution containing 5.2 × 102 fifty-percent-tissue-culture-infective-dose (TCID50)/ml.
    • The assessment of the April 2020 chernobyl wildfires and their impact on Cs-137 levels in Belgium and The Netherlands.

      De Meutter, Pieter; Gueibe, Christophe; Tomas, Jasper; Outer, Peter den; Apituley, Arnoud; Bruggeman, Michel; Camps, Johan; Delcloo, Andy; Knetsch, Gert-Jan; Roobol, Lars; et al. (2021-07-08)
    • Vitek 2 MICs as first-line phenotypic screening method for carbapenemase-producing .

      Sieswerda, Elske; Bosch, Thijs; Lankelma, Jacqueline M; Schouls, Leo M; Dijk, Karin van (2021-07-07)
      Aim: To define sensitivity and specificity of Vitek® 2 MICs as phenotypic screening method for carbapenemase-producing Pseudomonas aeruginosa. Materials & methods: We determined Vitek® 2 MICs of antipseudomonal antimicrobials in 130 unrelated carbapenemase-producing P. aeruginosa and 129 carbapenemase-negative P. aeruginosa isolates within a Dutch carbapenemase-surveillance database. We calculated test characteristics of single and combined antimicrobial MICs for carbapenemase production. Results: Vitek® 2 MIC above epidemiological cutoff of both imipenem and tobramycin or ciprofloxacin and tobramycin displayed a sensitivity of 96.2% and specificity of 89.6% for carbapenemase production in P. aeruginosa. Conclusion: Vitek® 2 MIC> epidemiological cut-off values seem sensitive and specific as a phenotypic screening strategy for carbapenemase-producing P. aeruginosa. Combining imipenem and tobramycin or ciprofloxacin and tobramycin performed best as a screening strategy for defining which P. aeruginosa isolates should undergo confirmatory tests for carbapenemase production.
    • Recommendations to plan a national burden of disease study.

      Haneef, Romana; Schmidt, Jürgen; Gallay, Anne; Devleesschauwer, Brecht; Grant, Ian; Rommel, Alexander; Wyper, Grant Ma; van Oyen, Herman; Hilderink, Henk; Ziese, Thomas; et al. (2021-07-07)
    • How to: prophylactic interventions for prevention of Clostridioides difficile infection.

      Reigadas, E; van Prehn, J; Falcone, M; Fitzpatrick, F; Vehreschild, M J G T; Kuijper, E J; Bouza, E (2021-07-07)
    • Population genetics, invasion pathways and public health risks of the raccoon and its roundworm Baylisascaris procyonis in northwestern Europe.

      Maas, Miriam; Tatem-Dokter, Rea; Rijks, Jolianne M; Dam-Deisz, Cecile; Franssen, Frits; van Bolhuis, Hester; Heddergott, Mike; Schleimer, Anna; Schockert, Vinciane; Lambinet, Clotilde; et al. (2021-07-05)
    • Exploring the gateway hypothesis of e-cigarettes and tobacco: a prospective replication study among adolescents in the Netherlands and Flanders.

      Martinelli, Thomas; Candel, Math J J M; de Vries, Hein; Talhout, Reinskje; Knapen, Vera; van Schayck, Constant P; Nagelhout, Gera E (2021-07-05)
      Studies demonstrated that adolescent e-cigarette use is associated with subsequent tobacco smoking, commonly referred to as the gateway effect. However, most studies only investigated gateways from e-cigarettes to tobacco smoking. This study replicates a cornerstone study revealing a positive association between both adolescent e-cigarette use and subsequent tobacco use; and tobacco and subsequent e-cigarette use in the Netherlands and Flanders.
    • Monitoring and risk assessment of hazardous chemicals in toy-slime and putty in The Netherlands.

      Braver, M W den; Schakel, D J; Hendriks, H S; Schuur, A G; Brand, W; Sijm, D T H M; Bouma, K (2021-07-04)
    • A mandatory indication-registration tool in hospital electronic medical records enabling systematic evaluation and benchmarking of the quality of antimicrobial use: a feasibility study.

      van den Broek, Annemieke K; Beishuizen, Berend H H; Haak, Eric A F; Duyvendak, Michiel; Ten Oever, Jaap; Sytsma, Chris; van Triest, Mieke; Wielders, Cornelia C H; Prins, Jan M (2021-07-03)
    • Socioeconomic differences in healthcare expenditure and utilization in The Netherlands.

      Loef, Bette; Meulman, Iris; Herber, Gerrie-Cor M; Kommer, Geert Jan; Koopmanschap, Marc A; Kunst, Anton E; Polder, Johan J; Wong, Albert; Uiters, Ellen (2021-07-03)